Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy (print-ISSN 0066-4804, CODEN AMACCQ; canceled ISSN 0074-9923, canceled CODEN AACHAX) is an academic journal published by the American Society for Microbiology. Antimicrobial Agents and Chemotherapy is a major forum devoted exclusively to antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy. It is a key resource for microbiologists, researchers, biochemists, pharmacologists, clinicians, and other specialist in infectious diseases.

Website
http://aac.asm.org/

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Two drugs show promise against COVID-19

Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for other illnesses, seem promising. The FDA approval for other uses would greatly reduce the time ...

Diseases, Conditions, Syndromes

Researchers' discovery may explain difficulty in treating Lyme disease

Northeastern University researchers have found that the bacterium that causes Lyme disease forms dormant persister cells, which are known to evade antibiotics. This significant finding, they said, could help explain why it's ...

HIV & AIDS

Stopping HIV in its tracks

Is the end of HIV near? Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread ...

Medications

Why lopinavir and hydroxychloroquine do not work on COVID-19

Lopinavir is a drug against HIV; hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2. A research group from ...

Diseases, Conditions, Syndromes

Addressing superbug resistance with phage therapy

International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Diseases, Conditions, Syndromes

New tuberculosis drug may shorten treatment time for patients

A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much ...

page 1 from 14